Properties
Description
cis-Pralsetinib primarily acts by blocking the ATP-binding site of the kinase domain of the RET protein, thereby inhibiting its autophosphorylation.
Molecular Formula
C27H32FN9O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
cis-Pralsetinib can be used to study its selective inhibition of RET kinase in oncology research.